Xu Z - Search Results

1

Discovery of Potential Flavonoid Inhibitors Against COVID-19 3CL Proteinase Based on Virtual Screening Strategy.

Xu Z, Yang L, Zhang X, Zhang Q, Yang Z, Liu Y, Wei S, Liu W. Xu Z, et al. Front Mol Biosci. 2020 Sep 29;7:556481. doi: 10.3389/fmolb.2020.556481. eCollection 2020. Front Mol Biosci. 2020. PMID: 33134310 Free PMC article.

2

A Gold(I) Complex Containing an Oleanolic Acid Derivative as a Potential Anti-Ovarian-Cancer Agent by Inhibiting TrxR and Activating ROS-Mediated ERS.

Bian M, Sun Y, Liu Y, Xu Z, Fan R, Liu Z, Liu W. Bian M, et al. Among authors: xu z. Chemistry. 2020 Jun 2;26(31):7092-7108. doi: 10.1002/chem.202000045. Epub 2020 Mar 25. Chemistry. 2020. PMID: 32037581

3

Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.

Che YH, Xu ZR, Ni LL, Dong XX, Yang ZZ, Yang ZB. Che YH, et al. J Ethnopharmacol. 2022 Mar 1;285:114851. doi: 10.1016/j.jep.2021.114851. Epub 2021 Nov 19. J Ethnopharmacol. 2022. PMID: 34808299

4

Pt(II)-NHC Complex Induces ROS-ERS-Related DAMP Balance to Harness Immunogenic Cell Death in Hepatocellular Carcinoma.

Bian M, Fan R, Yang Z, Chen Y, Xu Z, Lu Y, Liu W. Bian M, et al. Among authors: xu z. J Med Chem. 2022 Feb 10;65(3):1848-1866. doi: 10.1021/acs.jmedchem.1c01248. Epub 2022 Jan 13. J Med Chem. 2022. PMID: 35025488

5

Repurposing of the gold drug auranofin and a review of its derivatives as antibacterial therapeutics.

Liu Y, Lu Y, Xu Z, Ma X, Chen X, Liu W. Liu Y, et al. Among authors: xu z. Drug Discov Today. 2022 Jul;27(7):1961-1973. doi: 10.1016/j.drudis.2022.02.010. Epub 2022 Feb 19. Drug Discov Today. 2022. PMID: 35192926 Review.

6

Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma.

Xu Z, Xu J, Sun S, Lin W, Li Y, Lu Q, Li F, Yang Z, Lu Y, Liu W. Xu Z, et al. Among authors: xu j. Redox Biol. 2022 Aug;54:102351. doi: 10.1016/j.redox.2022.102351. Epub 2022 May 28. Redox Biol. 2022. PMID: 35671636 Free PMC article.

7

Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis.

Yang Z, Huang S, Liu Y, Chang X, Liang Y, Li X, Xu Z, Wang S, Lu Y, Liu Y, Liu W. Yang Z, et al. Among authors: xu z. J Med Chem. 2022 Jun 23;65(12):8401-8415. doi: 10.1021/acs.jmedchem.2c00300. Epub 2022 Jun 10. J Med Chem. 2022. PMID: 35687871

8

NSAID-Au(I) Complexes Induce ROS-Driven DAMPs and Interpose Inflammation to Stimulate the Immune Response against Ovarian Cancer.

Xu Z, Lu Q, Shan M, Jiang G, Liu Y, Yang Z, Lu Y, Liu W. Xu Z, et al. J Med Chem. 2023 Jun 22;66(12):7813-7833. doi: 10.1021/acs.jmedchem.3c00063. Epub 2023 Jun 8. J Med Chem. 2023. PMID: 37291753

9

A terbium(III) complex-based time-resolved luminescent probe for selenocysteine as an inhibitor of selenoproteins.

Chen J, Gao F, Xu Z, Liu Y, Hu M, Yuan C, Zhang Y, Liu W, Wang X. Chen J, et al. Among authors: xu z. Chem Commun (Camb). 2024 Feb 1;60(11):1440-1443. doi: 10.1039/d3cc05680e. Chem Commun (Camb). 2024. PMID: 38206371

10

Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma.

Li F, Wen Z, Wu C, Yang Z, Wang Z, Diao W, Chen D, Xu Z, Lu Y, Liu W. Li F, et al. Among authors: xu z. J Med Chem. 2024 Feb 8;67(3):1982-2003. doi: 10.1021/acs.jmedchem.3c01785. Epub 2024 Jan 23. J Med Chem. 2024. PMID: 38261008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39,005 results

Search Page

Filters